| Dynarrestin |
Dynarrestin |
2222768-84-3 |
| THAL-SNS-032 |
THAL-SNS-032 |
2139287-33-3 |
| pilaralisib |
2-氨基-N-[3-[N-[3-[(2-氯-5-甲氧基苯基)氨基]喹喔啉-2-基]氨基磺酰基]苯基]-2-甲基丙酰胺 |
934526-89-3 |
| ABBV-075 |
米维布塞 |
1445993-26-9 |
| Ozanimod |
奥扎莫德 |
1306760-87-1 |
| CYC-065 |
CYC-065 |
1070790-89-4 |
| NITD-349 |
1473450-62-2 |
1473450-62-2 |
| PF-06882961 |
PF-06882961 |
2230198-02-2 |
| MLN-120B |
N-(6-氯-7-甲氧基-9H-吡啶并[3,4-B]吲哚-8-基)-2-甲基-3-吡啶甲酰胺 |
783348-36-7 |
| SAR407899 |
SAR407899 |
923359-38-0 |
| GSK-2256098 |
GSK-2256098 |
1224887-10-8 |
| PAC1 |
PAC1 |
315183-21-2 |
| NS-398 |
抑制剂 |
123653-11-2 |
| CHK2 INHIBITOR II |
2-(4-(4-CHLOROPHENOXY)PHENYL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXAMIDE |
516480-79-8 |
| (S)-2-(6-bromobenzo[d][1,3]dioxol-5-yl)-N-(4-cyanophenyl)-1-(1-cyclohexylethyl)-1H-benzo[d]imidazole-5-carboxamide |
(S)-2-(6-溴苯并[D][1,3]二氧杂环戊烯-5-基)-N-(4-氰基苯基)-1-(1-环己基乙基)-1H-苯并[D]咪唑-5-甲酰胺 |
2100284-59-9 |
| LY2603618 |
LY2603618 |
911222-45-2 |
| KX2-391 |
5-[4-[2-(4-吗啉基)乙氧基]苯基]-N-(苯基甲基)-2-吡啶乙酰胺 |
897016-82-9 |
| Luminespib |
NVP-AUY922 |
747412-49-3 |
| LY2109761 |
LY2109761 |
700874-71-1 |
| STING agonist-1 |
702662-50-8 |
702662-50-8 |
QQ
微信
